Day One Biopharmaceuticals, Inc. Common Stock Profile
About
Day One Biopharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It dedicated to developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Day One Biopharmaceuticals Inc. is based in SOUTH SAN FRANCISCO, Calif.
Info & Links
CEO
Jeremy Bender
Headquarters
2000 Sierra Point Parkway, Suite 501 Brisbane, CA 94005, UNITED STATES
Day One Biopharmaceuticals, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
1.24B
Enterprise Value
817.75M
Enterprise Value/EBITDA(ttm)
-3.89
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
2.14
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
47.42%
Operating Margin(ttm)
--
Profit Margin(ttm)
-3.57%
Return on Equity(ttm)
-22.40%
Return on Invested Capital(ttm)
-31.53%
Return on Assets(ttm)
-19.79%
Income Statement
Revenue(ttm)
101.95M
Revenue Per Share(ttm)
1.01
Gross Profit(ttm)
99.66M
EBITDA(ttm)3
-210.08M
Net Income Available to Common(ttm)
-84.29M
Diluted EPS(ttm)
-1.03
Share Statistics
Beta (5Y Monthly)
-1.46
52-Week Change
-17.39%
S&P 500 52-Week Change
22.34%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
100.85M
Dividend Yield
0.00%
Float4
92.38M
% Held by Insiders
8.40%
% Held by Institutions
87.95%
Balance Sheet
Total Cash(mrq)
558.38M
Total Cash Per Share(mrq)
5.54
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
14.62%
Quick Ratio(mrq)
14.55%
Book Value Per Share(mrq)
5.51
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.50
Free Cash Flow(ytd)
-48.85M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.